Edward J. Sitar
2021 - 9 METERS BIOPHARMA
In 2021, Edward J. Sitar earned a total compensation of $1M as Chief Financial Officer at 9 METERS BIOPHARMA, a 30% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $118,880 |
|---|---|
| Option Awards | $523,489 |
| Salary | $371,500 |
| Total | $1,013,869 |
Sitar received $523.5K in option awards, accounting for 52% of the total pay in 2021.
Sitar also received $118.9K in non-equity incentive plan and $371.5K in salary.
Rankings
In 2021, Edward J. Sitar's compensation ranked 8,756th out of 12,415 executives tracked by ExecPay. In other words, Sitar earned more than 29.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,756 out of 12,415 | 30th |
Division Manufacturing | 3,882 out of 5,505 | 30th |
Major group Chemicals And Allied Products | 1,715 out of 2,375 | 28th |
Industry group Drugs | 1,526 out of 2,096 | 27th |
Industry Pharmaceutical Preparations | 1,136 out of 1,546 | 27th |
Source: SEC filing on May 13, 2022.
Sitar's colleagues
We found one more compensation record of an executive who worked with Edward J. Sitar at 9 METERS BIOPHARMA in 2021.
2021
John Temperato
9 METERS BIOPHARMA